Tamara King, PhD, said she hopes the grant from the Main Cancer Society will allow her to pursue research that enables future cancer patients to alleviate pain while preserving mental ability. She will work to develop an antibody that targets and deactivates the interleukin-6 molecules, which are responsible for bone pain felt during cancer.
Related Articles on Pain Management:
Memorial Hospital of Union County, Pain Management Group Open Pain Center
FDA Accepts Zogenix Chronic Pain Drug for Review
10 Interventional Pain Management Specialists Founding Ambulatory Surgery Centers
